Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Feasibility and Acceptability Study of the "O'Dide" Application in People Suffering From an Addiction (FA-O'DIDE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04659954
Recruitment Status : Not yet recruiting
First Posted : December 9, 2020
Last Update Posted : December 9, 2020
Sponsor:
Collaborator:
Institut de Recherche en Santé Publique, France
Information provided by (Responsible Party):
University Hospital, Toulouse

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
Substance Use Disorders (SUD) are associated with cognitive schemas that lead to care attrition and mistrust towards care. Considering this within SUD management, it is important to establish a confident relation between the patient and the care team to favorize acre observance. However, it demands an important availability of the healthcare team, allowing for frequent interactions at all times, including at night and during days off. We postulated that an application called Ô DIDE for Digital Interaction for Detoxification Engagement, that aims to help the caregivers maintaining a link with the patient in order to facilitate confidence in the relationship, could favorize care observance especially consumption report.

Condition or disease Intervention/treatment Phase
Substance-Related Disorders Personality Disorders Other: Application O'DIDE Not Applicable

Detailed Description:
The present research aims to assess the feasibility of the "Ô DIDE" application after 8 weeks of use by patients treated for a disorder related to substance use at the Toulouse University Hospital.
Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 30 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Other
Official Title: Feasibility and Acceptability Study of the "O'Dide" Application in People Suffering From an Addiction
Estimated Study Start Date : April 2021
Estimated Primary Completion Date : April 2022
Estimated Study Completion Date : April 2022
Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: Application O'DIDE
The subjects will use the application O'DIDE during 8 weeks
 Other: Application O'DIDE
The intervention is the use of an application that aimed to favorize contact between the patient and the care team between the consultations.


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Feasibility of the application O'DIDE [ Time Frame: 8 weeks ]
    Percentage of patients who logged on at least once a week to the application during the 8 weeks of availability of the O'DIDE application


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Suffering from any type of addiction, with an active addiction requiring weekly monitoring of consumption
  • Possessing an Android smartphone or having access to an Android smartphone and having access to an internet connection
  • Able to read and understand French
  • Affiliated or beneficiary of a social security scheme.
  • Free, informed and written consent signed by the participant and the investigator (at the latest on the day of inclusion and before any examination required by the research).

Exclusion Criteria:

  • Patient with cognitive or psychiatric disorders that may affect their ability to consent
  • Participation in another protocol involving a modification of the treatment for addiction
  • Person under legal protection, guardianship or curatorship
  • Known or suspected pregnancy
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04659954


Contacts
Layout table for location contacts
Contact: Juliette Salles, MD 33-561777307 salles.j@chu-toulouse.fr

Locations
Layout table for location information
France
University hospital of Toulouse
Toulouse, France, 31059
Contact: Juliette SALLES, MD         
Principal Investigator: Juliette SALLES, MD         
Sub-Investigator: Nicolas NAVARRO, MD         
Sponsors and Collaborators
University Hospital, Toulouse
Institut de Recherche en Santé Publique, France
Investigators
Layout table for investigator information
Principal Investigator: Juliette Salles, MD University Hospital, Toulouse
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: University Hospital, Toulouse
ClinicalTrials.gov Identifier: NCT04659954    
Other Study ID Numbers: RC31/20/0367
First Posted: December 9, 2020    Key Record Dates
Last Update Posted: December 9, 2020
Last Verified: December 2020

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by University Hospital, Toulouse:
E health
Application
Substance use disorders
Personality disorders
Care observance
Additional relevant MeSH terms:
Layout table for MeSH terms
Disease
Substance-Related Disorders
Personality Disorders
 Pathologic Processes
Mental Disorders
Chemically-Induced Disorders